What's New In FDA's Updated Data Monitoring Guidance
On Feb. 13, the U.S. Food and Drug Administration published a draft guidance on the use of data monitoring committees, or DMCs, in clinical trials, titled "Use of Data Monitoring Committees...To view the full article, register now.
Already a subscriber? Click here to view full article